Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,940.00p on 30-07-2026 at 17:05:07
Change -67.00p -3.34%
Buy 1,936.50p
Sell 1,935.50p
Last Trade: Sell 619.00 at 1,940.00p
Day's Volume: 7,052,592
Last Close: 1,940.00p
Open: 1,988.50p
ISIN: GB00BN7SWP63
Day's Range 1,935.50p - 1,994.50p
52wk Range: 1,361.00p - 2,282.00p
Market Capitalisation: £77.73b
VWAP: 1,951.6932p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 619 1,940.00p Ordinary
16:49:50 - 30-Jul-26
Unknown* 483,191 1,948.125p SI Trade
Negotiated Trade
16:45:35 - 30-Jul-26
Buy* 1,619 1,940.00p Automatic Execution
16:39:00 - 30-Jul-26
Buy* 100 1,940.00p Automatic Execution
16:39:00 - 30-Jul-26
Buy* 1,100 1,940.00p Automatic Execution
16:39:00 - 30-Jul-26
Buy* 200 1,940.00p Automatic Execution
16:36:45 - 30-Jul-26
Buy* 750 1,940.00p Automatic Execution
16:36:45 - 30-Jul-26
Buy* 175 1,940.00p Automatic Execution
16:36:45 - 30-Jul-26
Buy* 175 1,940.00p Automatic Execution
16:36:45 - 30-Jul-26
Buy* 199 1,940.00p Automatic Execution
16:36:28 - 30-Jul-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Jul 2026 (Wed) 2,027.00 2,048.00 1,981.50 2,007.00 8,560,854
28th Jul 2026 (Tue) 1,969.50 2,096.00 1,926.00 2,029.00 18,383,205
27th Jul 2026 (Mon) 1,940.00 1,980.00 1,932.00 1,961.00 13,331,274
24th Jul 2026 (Fri) 1,893.00 1,933.50 1,893.00 1,919.50 5,842,856
23rd Jul 2026 (Thu) 1,894.50 1,905.50 1,866.00 1,905.50 8,013,378
22nd Jul 2026 (Wed) 1,887.00 1,936.50 1,882.00 1,910.50 4,480,225
21st Jul 2026 (Tue) 1,858.00 1,913.00 1,851.50 1,893.00 19,807,282
20th Jul 2026 (Mon) 1,909.00 1,920.00 1,881.00 1,882.00 9,594,138
17th Jul 2026 (Fri) 1,966.00 1,982.00 1,868.00 1,916.50 13,825,247
16th Jul 2026 (Thu) 1,904.00 1,958.00 1,896.00 1,956.00 5,092,934
15th Jul 2026 (Wed) 1,920.50 1,929.00 1,903.50 1,916.50 8,355,831
14th Jul 2026 (Tue) 1,956.00 1,957.50 1,905.00 1,920.50 4,279,605
13th Jul 2026 (Mon) 1,960.00 1,983.50 1,934.00 1,953.50 4,209,058
10th Jul 2026 (Fri) 1,963.50 1,981.00 1,954.00 1,961.50 6,365,614
9th Jul 2026 (Thu) 1,960.00 1,982.50 1,951.00 1,959.50 5,592,231
8th Jul 2026 (Wed) 1,990.50 1,990.50 1,964.00 1,979.50 4,243,160
7th Jul 2026 (Tue) 1,998.00 2,031.00 1,982.00 2,003.00 4,183,205
6th Jul 2026 (Mon) 2,025.00 2,048.00 1,967.50 1,983.00 15,157,640
3rd Jul 2026 (Fri) 2,005.00 2,015.00 1,988.00 2,015.00 2,548,103
2nd Jul 2026 (Thu) 1,949.00 2,014.00 1,943.00 2,004.00 17,566,583
1st Jul 2026 (Wed) 1,981.00 1,992.00 1,930.00 1,930.00 8,817,916
30th Jun 2026 (Tue) 1,999.50 2,009.00 1,946.50 1,981.00 13,957,667
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
28th Jul 2026 12:05 pm RNS New GSK flagship R&D centre in Cambridge
28th Jul 2026 12:00 pm RNS 2nd Quarter Results
28th Jul 2026 11:06 am RNS Hansoh positive 2nd Phase III results for Riz-Rez
24th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
24th Jul 2026 3:00 pm RNS Admission to Trading
22nd Jul 2026 5:22 pm RNS Jideytro approved in US for certain lung cancers
20th Jul 2026 7:00 am RNS Bexsero 1-dose booster EMA file acceptance
17th Jul 2026 12:00 pm RNS Audit tender conclusion
17th Jul 2026 9:30 am RNS Camlipixant phase III results update
16th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

WINNERS & LOSERS: Rolls-Royce ups guide; Rentokil slumps

30th Jul 2026 11:05

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON BROKER RATINGS: Berenberg raises Rio Tinto; HSBC ups Centrica

30th Jul 2026 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET CLOSE: Earnings tonic boosts FTSE 100 as oil falls back

28th Jul 2026 17:09

(Alliance News) - The FTSE 100 made strong progress on Tuesday, buoyed by positive earnings and a drop in the oil price, which helped shrug off worries sparked by a chip sector sell-off in Asia. Read More

GSK targets GBP1.9 billion in cost savings as profit beats forecast

28th Jul 2026 12:39

(Alliance News) - GSK PLC on Tuesday said it was planning a cost savings drive to fund investment in late-stage drug development as it reported second quarter results ahead of expectations. Read More

GSK celebrates Hansoh's positive results from Ris-Rez phase 3 trial

28th Jul 2026 11:58

(Alliance News) - GSK PLC on Tuesday notes that licensor Hansoh Pharmaceutical Group Co Ltd has announced positive results from a "pivotal" phase 3 study of risvutatug rezetecan, or Ris-Rez. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,897.27
Change-11.14

Login to your account

Forgot Password?

Not Registered